These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12916794)

  • 1. New treatment options for chronic hepatitis C.
    van Soest H; van Hattum J
    Adv Exp Med Biol; 2003; 531():219-26. PubMed ID: 12916794
    [No Abstract]   [Full Text] [Related]  

  • 2. [Current Guidelines for treatment of hepatitis C. The eradication of HCV as a goal].
    Sarrazin C; Zeuzem S
    Pharm Unserer Zeit; 2011 Jan; 40(1):52-9. PubMed ID: 21194083
    [No Abstract]   [Full Text] [Related]  

  • 3. [Change of HCV-RNA levels in liver tissue and interferon responsiveness in patients with chronic hepatitis C].
    Takeuchi M; Kaneko S; Unoura M; Kobayashi K
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):969-74. PubMed ID: 7563912
    [No Abstract]   [Full Text] [Related]  

  • 4. Novel hepatitis C drugs in current trials.
    Kronenberger B; Welsch C; Forestier N; Zeuzem S
    Clin Liver Dis; 2008 Aug; 12(3):529-55, viii. PubMed ID: 18625427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of chronic hepatitis C virus infection: a clinical and virological perspective.
    Gretch DR; Polyak SJ; Willson RA; Carithers RL
    Adv Exp Med Biol; 1996; 394():207-24. PubMed ID: 8815687
    [No Abstract]   [Full Text] [Related]  

  • 6. Form confers function: Case of the 3'X region of the hepatitis C virus genome.
    Dutkiewicz M; Ciesiołka J
    World J Gastroenterol; 2018 Aug; 24(30):3374-3383. PubMed ID: 30122877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [BMS-790 052 - an oral antiviral hepatitis C antiviral in the pipeline].
    Schmitz J
    Pharm Unserer Zeit; 2011 Jan; 40(1):8-9. PubMed ID: 21194074
    [No Abstract]   [Full Text] [Related]  

  • 8. [HCV-RNA in liver of chronic hepatitis C--plus strand RNA and minus strand RNA].
    Endo H; Yamada G
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):623-8. PubMed ID: 7563844
    [No Abstract]   [Full Text] [Related]  

  • 9. [HCV-RNA quantity of the serum].
    Sasaki Y; Hige S; Nagasaka A; Matsushima T
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):965-8. PubMed ID: 7563911
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatitis C treatment update.
    Pearlman BL
    Am J Med; 2004 Sep; 117(5):344-52. PubMed ID: 15336584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interferon sensitivity determining region: all hepatitis C virus isolates are not the same.
    Herion D; Hoofnagle JH
    Hepatology; 1997 Mar; 25(3):769-71. PubMed ID: 9049233
    [No Abstract]   [Full Text] [Related]  

  • 12. [Interferon therapy for acute hepatitis C: evaluation by HCV antibody, HCV genotypes and serum RNA titer].
    Toyama H; Iwabuchi S
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):521-7. PubMed ID: 7563813
    [No Abstract]   [Full Text] [Related]  

  • 13. Hepatitis C: changing genotype distribution with important implications for patient management.
    van Soest H; Boland GJ; van Erpecum KJ
    Neth J Med; 2006 Apr; 64(4):96-9. PubMed ID: 16609154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Future options for the management of hepatitis C.
    Davis GL; Nelson DR; Reyes GR
    Semin Liver Dis; 1999; 19 Suppl 1():103-12. PubMed ID: 10349698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oligonucleotide-based therapeutic options against hepatitis C virus infection.
    Trepanier JB; Tanner JE; Alfieri C
    Antivir Ther; 2006; 11(3):273-87. PubMed ID: 16759043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tailored treatment for hepatitis C.
    Berg T
    Clin Liver Dis; 2008 Aug; 12(3):507-28, vii-viii. PubMed ID: 18625426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical evaluation of positive- and negative-stranded HCV-RNAs in liver in relation to IFN therapy].
    Hino K; Murakami C; Fujii K; Okazaki M; Okuda M; Hanada H; Okita K
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):949-53. PubMed ID: 7563907
    [No Abstract]   [Full Text] [Related]  

  • 18. Accurate hepatitis C virus genotyping and selection of optimal therapy: lessons from a St Petersburg strain infection.
    Knops E; Heger E; Koenig C; Moebius U; Lübke N; Kaiser R; Di Cristanziano V; Hüsgen L; Kocyigit C; Rupp J; Sierra S
    Clin Microbiol Infect; 2018 Apr; 24(4):440-441. PubMed ID: 29104172
    [No Abstract]   [Full Text] [Related]  

  • 19. Current therapy of hepatitis C.
    de Knegt RJ
    Scand J Gastroenterol Suppl; 2006; (243):65-9. PubMed ID: 16782624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapeutic response to alpha-interferon in chronic alcoholics with viral hepatitis C].
    Nikitin IG; Kuznetsov SL; Liuliaeva OD; Storozhakov GI; Kisliakov VA; Uskov IuI
    Klin Med (Mosk); 1998; 76(8):33-5. PubMed ID: 9770965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.